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Graphical Abstract 
 
A 9-year-old neutered male crossbred dog with a 4-week history of progressive 
vestibulocerebellar signs was presented for necropsy examination. Gross and histological 
examination led to the diagnosis of pulmonary basaloid squamous cell carcinoma with 
metastases in thoracic lymph nodes, the left kidney and cerebellum. 
 
Summary 
A 9-year-old neutered male crossbred dog with a 4-week history of progressive 
vestibulocerebellar signs was presented for necropsy examination. Gross examination 
revealed neoplastic growth in the lungs, thoracic lymph nodes, the left kidney and the 
cerebellum.  Microscopically, the tumour consisted of an infiltrative, densely cellular, 
basaloid epithelial neoplastic growth with extensive areas of abrupt keratinization. 
Immunohistochemically, neoplastic cells expressed p63 and partially expressed cytokeratins 
5/6.  Based on these findings, the tumour was diagnosed as a primary pulmonary basaloid 
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squamous cell carcinoma (BSSC) with metastasis to regional lymph nodes, kidney and brain. 
As far as the authors are aware, this is the first description of BSCC in an animal species. 
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Lung neoplasia is uncommon in domestic animals, apart from in dogs and cats.  The 
incidence of canine lung neoplasia increases with age and the most common primary tumour 
is bronchioalveolar carcinoma.  Adenocarcinomas, adenosquamous and squamous cell 
carcinomas (SCCs) are less common (Meuten, 2017). 
Basaloid squamous cell carcinoma (BSCC) is a rare neoplasm of the lung, which was 
first described in man in 1992 (Brambilla et al., 1992).  In the current 2015 World Health 
Organization (WHO) tumour classification, BSCC is considered to be a subtype of SCC 
(Travis et al., 2015).  Squamous markers, such as p40 and p63, are expressed consistently in 
BSCC (Bishop et al., 2012; Travis et al., 2015).  Other lung tumour subtypes of SCC include 
keratinizing squamous cell carcinoma, non-keratinizing squamous cell carcinoma and 
squamous cell carcinoma in situ (Travis et al., 2015).  Comprehensive descriptions of 
pulmonary BSCC appear to be lacking in animals.  One case report describes a poorly 
differentiated, not further classified, pulmonary SCC in a dolphin with histological features 
potentially compatible with BSCC (Ewing and Mignucci-Giannoni, 2003). 
A 9-year-old neutered male crossbred dog was submitted for post-mortem 
examination. The animal was presented 3 days before for neurological examination with a 4-
week history of progressive vestibulocerebellar signs.  Serum biochemistry revealed elevated 
alkaline phosphatase (412.0 U/l, reference range <130.0 U/l), total bilirubin (8.6 µmol/l, 
reference range 0.1-4.2 µmol/l) and creatine kinase (CK) (334.0 U/l, reference range 20.0–
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225.0 U/l) and a low sodium:potassium ratio (27.4, reference range 28.8–40.0).  Neurological 
examination localized a lesion within the caudal cranial fossa affecting the 
vestibulocerebellar structures.  A degree of left lateralization of the lesion was considered 
possible based on the observed proprioceptive deficits.  At this point, the main differential 
diagnoses included neoplasia or inflammatory disease.  A magnetic resonance imaging (MRI) 
examination of the brain revealed a rim-enhancing cerebellar mass measuring 1.1 × 1.3 cm 
located in the centre of the cerebellum, with associated perilesional oedema.  Mild central 
compression of the brainstem and mild rostral transtentorial herniation with extension to the 
foramen magnum was observed.  Cerebrospinal fluid (CSF) analysis revealed moderate to 
severe ‘albuminocytological dissociation’ (protein 2.40 g/l, reference range 0.14–0.30 g/l; 
nucleated cell count 3.0 × 109/l, reference range 0–6 × 109/l). 
Given the clinical findings, the presence of a neoplastic lesion was considered highly 
likely, although an inflammatory lesion could not be excluded based on the diagnostic tests 
performed.  Medical management with glucocorticoids and possible chemotherapy was 
proposed to the owners.  However, the owners elected for humane destruction based on the 
poor prognosis and quality of life, and gave consent for a full post-mortem examination. 
On gross examination, the main lesions were observed in the lung, the left kidney and 
the cerebellum. The lung contained multifocal, variably sized, 0.3–4.0 cm diameter, raised 
spherical nodules which were pale tan in colour, often umbilicated, poorly demarcated, solid 
and with a firm, often gritty consistency.  The two largest masses measured up to 3.5 × 3.0 × 
4.0 cm and were located at the level of the bifurcation of the main bronchi and within the 
mediastinal edge of the left caudal lobe (Fig. 1).  The remaining lung tissue was diffusely 
dark red, wet and heavy, compatible with congestion and oedema.  Mediastinal, 
tracheobronchial and bronchial lymph nodes were enlarged (up to 1 × 1.5 cm) and expanded 
by similar tissue as described in the lungs, compatible with tumour metastasis.  The left 
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kidney contained a focal wedge-shaped, 0.6 × 0.8 × 0.5 cm, pale tan, solid mass within the 
cortex, compatible with tumour metastasis.  On coronal serial sections of the brain, at the 
level of cerebellum and brainstem, a focal, irregularly-shaped, poorly-demarcated, 
infiltrative, non-encapsulated, pale tan and firm mass was located centrally in the white 
matter of the cerebellum between the fourth ventricle and the cerebellar vermis (Fig. 2). 
Samples of all the main organs and lesions were fixed in 10% neutral buffered formalin, 
processed routinely and embedded in paraffin wax. 
Microscopically, the lung nodules corresponded to non-encapsulated, infiltrative, 
densely cellular epithelial proliferations with extensive areas of abrupt keratinization (Fig. 3). 
The cells were mostly closely packed in a lobular or cribriform pattern, appeared basaloid 
and were supported by dense fibrous stroma.  Proliferating, interpreted as neoplastic, cells 
often lined extensive lakes of keratin, and were round to polygonal, with round, 
hyperchromatic nuclei and mostly scant cytoplasm.  Nuclear palisading was frequent, 
compatible with a basaloid cellular differentiation.  Distinct intercellular bridges were not 
observed.  Mitotic activity was moderate (0–6 mitoses per ×400 high power field). Within the 
cellular mass there were multifocal extensive areas of necrosis, some admixed with abundant 
neutrophils and often with foci of dystrophic calcification. Multifocal intrapulmonary 
micrometastases were present.  
In the cerebellum, the mass consisted of a focally extensive, highly infiltrative 
epithelial mass, interpreted as neoplastic with a histological appearance comparable with the 
neoplastic nodules described in the lungs.  A large central area of coagulative necrosis was 
present.  There was marked spongiosis and gliosis in the parenchyma surrounding the 
tumour. The lesions within the thoracic lymph nodes and the kidney corresponded to a 
cellular growth with histological features as described for the lungs and brain; these were 
interpreted as tumour metastases. 
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Immunohistochemically, neoplastic cells expressed p63 (Ventana Medical Systems, 
Inc., Tucson, Arizona, USA); anti-p63 [4A4] mouse monoclonal antibody; prediluted) and 
had partial expression of cytokeratin (CK) 5/6 (Ventana Medical Systems, Inc.; anti-
cytokeratin 5/6 [D5/16B4] mouse monoclonal; prediluted).  For both antibodies, human tonsil 
was used as positive control tissue and tissue sections were heat pretreated in cell 
conditioning solution 1 (Roche Diagnostics GmbH, Mannheim, Germany) at 95°C for 64 
min.  The labelling for p63 was diffuse, strong and nuclear (Fig. 4), while the CK 5/6 
labelling was strong and cytoplasmic with a variable percentage of positive cells within the 
tumour (ranging from <5% to >80%). 
Based on these findings, a final diagnosis of BSCC of the lung with metastases to 
thoracic lymph nodes, left kidney and cerebellum was made.  
Pulmonary BSCC are rare tumours, which are defined in man as a histological 
subtype of SCC, either keratinizing or non-keratinizing, with a basaloid component of >50% 
of the tumour (Travis et al., 2015).  In the new WHO lung tumour classification (Travis et al., 
2015), former basaloid carcinomas were moved from the category of large cell carcinoma to 
become a subtype of SCC.  This reclassification was based on the recognition that the former 
basaloid carcinomas express squamous markers, such as p40 or p63. Furthermore, genetic 
analyses of these tumours revealed a specific genetic profile, which is different from other, 
non-basaloid, SCCs (Brambilla et al., 2014).  For these reasons, the subtyping of SCC was 
modified to consist of keratinizing, non-keratinizing and basaloid subtypes.  Tumours are 
classified as BSCC if the basaloid component is >50% of the tumour, regardless of the 
presence of any keratinization.  In the present case, the basaloid component was almost 
diffuse and large lakes of abrupt keratinization were present, consistent with BSCC.  Features 
of progressive keratinization, including intercellular bridges were not evident in the samples 
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examined.  BSCC is a well-recognized tumour type in men in other non-respiratory organs 
such as head and neck, oesophagus and anal canal (Moro-Sibilot et al., 2008). 
Human pulmonary BSCC is a highly malignant tumour with a poor prognosis and a 
high rate of metastasis (Cakir et al., 2007; Moro-Sibilot et al., 2008; Wang et al., 2011). 
BSCC usually occurs in elderly men (Cakir et al., 2007). Interestingly, the dog in this case 
was also male and over 9 years old. The present canine case also showed widespread tumour 
metastasis involving thoracic organs, the brain and one kidney. The prognosis of human 
BSCC is worse than for non-basaloid SCC (Brambilla et al., 2014). A distinction between 
these two tumour entities is therefore justified and important. 
Immunohistochemical analysis of lung tumours is often needed for definitive 
characterization. Sensitive markers of squamous differentiation include cytokeratins 5/6 and 
p63 which are recommended for use in cases of suspected BSCC (Serrano et al., 2008). P63 
is a member of the p53 gene family and is expressed constitutively by a variety of epithelial 
stem cells, including squamous epithelia, urothelium, bronchial epithelium and the 
myoepithelial layers of breast, prostate and submucosal glands (Di Como et al., 2002; Wang 
et al., 2002; Yang et al., 2002; Emanuel et al., 2005). In normal lung tissue, intense nuclear 
p63 expression is seen in bronchial reserve cells, but not ciliated cells, alveolar epithelial cells 
or non-epithelial cells (Kaufmann et al., 2001; Di Como et al., 2002; Wang et al., 2002). In 
lung tumours, strong and consistent nuclear p63 expression is observed in SCCs, including 
BSCCs and poorly differentiated carcinomas (Kaufmann et al., 2001; Wang et al., 2002; 
Crapanzano et al., 2011; Pelosi et al., 2011). Small-cell carcinomas are described as p63 
negative, while bronchioloalveolar carcinomas and adenocarcinomas show variable 
expression. The present canine case had strong and diffuse nuclear expression of p63. CK 5 
and 6 are related proteins, often detected with the CK5/6 antibody. In normal adult tissues, 
the basal and myoepithelial cells of simple epithelia generally express CK5, while CK6 is 
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detected in normal non-cornifying stratified squamous epithelia (Jerome Marson et al., 2004); 
CK5 is present in all stratified squamous epithelia and is a more sensitive and specific marker 
than p63 (Brunnstrom et al., 2013). In lung tumours, strong and diffuse membranous CK5/6 
labelling can be observed in squamous pulmonary carcinomas and carcinomas with a 
squamous component (Jerome Marson et al., 2004; Pelosi et al., 2011; Brunnstrom et al., 
2013). All other primary pulmonary carcinomas fail to express significant CK5⁄6. The present 
canine case showed distinct and strong cytoplasmic CK5/6 labelling with a variable 
percentage of positive cells within the tumour, ranging from <5% to >80%. This irregular 
labelling pattern may potentially correspond to variable cellular differentiation within the 
tumour. Indeed, CK5/6 labelling intensity has been shown to correlate negatively with the 
degree of differentiation (Jerome Marson et al., 2004). 
This report indicates that BSCC can occur in dogs and that it can present with 
widespread metastasis and a poor prognosis, mimicking the human form of BSCC. Studies 
including a higher number of canine cases would be needed to effectively compare both 
human and canine BSCCs. To the authors’ knowledge this is the first report of a pulmonary 
BSCC in the peer-reviewed veterinary literature. 
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Figure Legends 
 
Fig. 1. Lung with BSCC, ventral view. Note the multiple, poorly demarcated, pale tan, 
slightly raised neoplastic nodules in the lung parenchyma. Remaining lung tissue is markedly 
congested and oedematous. Bar, 1 cm. 
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Fig. 2. Cerebellum and brainstem with metastatic pulmonary BSCC, coronal section. Note the 
focal, poorly-demarcated, pale mass (*) within the white cerebellar matter. Bar, 1 cm. 
 
Fig. 3. Pulmonary BSCC.  The tumour consists of a densely cellular basaloid epithelial 
neoplastic proliferation with extensive areas of abrupt keratinization. Haematoxylin and 
eosin.  Bar, 400 m. 
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Fig. 4. Pulmonary BSCC. Neoplastic cells show strong and diffuse nuclear expression of p63. 
Immunohistochemistry. Bar, 100 m. 
 
 
Supplementary Figure Legends 
 
Supplementary Fig. 1. Lung with a cut section of BSCC.  Remaining lung tissue is markedly 
congested and oedematous. Bar, 1 cm. 
 15 
 
Supplementary Fig. 2. Pulmonary BSCC with extensive areas of abrupt keratinization. 
Haematoxylin and eosin. Bar, 100 m. 
 
 
 
